Decreased lesion formation in CCR2-/- mice reveals a role for chemokines in the initiation of atherosclerosis.
about
Chemokine CCL2 and its receptor CCR2 are increased in the hippocampus following pilocarpine-induced status epilepticusIdentification of the binding site for a novel class of CCR2b chemokine receptor antagonists: binding to a common chemokine receptor motif within the helical bundleInduction of dendritic cell-like phenotype in macrophages during foam cell formationAn oxidized lipid-peroxisome proliferator-activated receptor gamma-chemokine pathway in the regulation of macrophage-vascular smooth muscle cell adhesionHuman LZIP induces monocyte CC chemokine receptor 2 expression leading to enhancement of monocyte chemoattractant protein 1/CCL2-induced cell migrationDifferential expression of three T lymphocyte-activating CXC chemokines by human atheroma-associated cellsImmunology. Dispensable but not irrelevantTwo Hsp70 family members expressed in atherosclerotic lesionsTargeted disruption of the class B scavenger receptor CD36 protects against atherosclerotic lesion development in miceMyeloid-related protein-8/14 is critical for the biological response to vascular injuryAtherosclerosisHMG-CoA reductase inhibition aborts functional differentiation and triggers apoptosis in cultured primary human monocytes: a potential mechanism of statin-mediated vasculoprotectionDifferential signaling mechanisms regulate expression of CC chemokine receptor-2 during monocyte maturation.MIF and CXCL12 in Cardiovascular Diseases: Functional Differences and SimilaritiesChemokines and their receptors in AtherosclerosisEmerging role of mast cells and macrophages in cardiovascular and metabolic diseasesChemokines and microRNAs in atherosclerosisInflammation and vascular injury: basic discovery to drug developmentRegulation of atherogenesis by chemokines and chemokine receptorsChemokines as effector and target molecules in vascular biologyDifferential modulation of retinal degeneration by Ccl2 and Cx3cr1 chemokine signallingElucidation of monocyte/macrophage dynamics and function by intravital imaging.Hydrogen sulfide inhibits the development of atherosclerosis with suppressing CX3CR1 and CX3CL1 expressionP2Y6 receptor potentiates pro-inflammatory responses in macrophages and exhibits differential roles in atherosclerotic lesion developmentEndothelial Response to Glucocorticoids in Inflammatory DiseasesThe Role of CC-Chemokines in the Regulation of AngiogenesisNonclassical patrolling monocyte function in the vasculatureMinireview: Emerging Concepts in Islet Macrophage Biology in Type 2 DiabetesCCR11 is a functional receptor for the monocyte chemoattractant protein family of chemokinesMonocyte chemoattractant protein-1 induces a novel transcription factor that causes cardiac myocyte apoptosis and ventricular dysfunctionOpportunities for the treatment of inflammation in cardiovascular diseaseAtherogenesis in perspective: hypercholesterolemia and inflammation as partners in crimeUse of cell permeable NBD peptides for suppression of inflammationThe role of fatty acid binding proteins in metabolic syndrome and atherosclerosisInflammatory cell recruitment in cardiovascular disease: murine models and potential clinical applicationsWound healing in MIP-1alpha(-/-) and MCP-1(-/-) miceNF-kappaB: pivotal mediator or innocent bystander in atherogenesis?Hypoxia induces expression of the chemokines monocyte chemoattractant protein-1 (MCP-1) and IL-8 in human dermal fibroblastsThe adhesion receptor CD44 promotes atherosclerosis by mediating inflammatory cell recruitment and vascular cell activationMonocyte chemoattractant protein 1 causes differential signalling mediated by proline-rich tyrosine kinase 2 in THP-1 cells
P2860
Q21245234-C12ADA47-5EC4-4F3B-A087-0FFF84648B73Q22253922-7EEAD7DD-2E5B-4BD4-ACAE-97146102E833Q24294246-261EDC54-4F5A-4C9F-9E5B-285D8D9C62BDQ24300694-840F8A56-2AF9-4F6A-AD58-C62A1F113725Q24336647-B03117DD-4EE6-4B34-B89B-C614DDC87DBFQ24563090-577495F5-A1A6-47E8-9570-69C5847D094CQ24595843-720F899C-2A18-4B72-8A79-5BD85A44A1ACQ24597133-8A391377-654D-415F-8634-509720004996Q24623151-23AA0325-6CD2-4A92-9A1D-673C92B1A332Q24627504-C20A7658-36A2-4E80-A525-4AB377CE5704Q24644573-1C49D962-A992-460D-BA5E-F93CA610B235Q24793685-60D5F51D-D094-49C2-9C7E-71952EE0C25DQ24815569-7BD2F784-D391-48AF-A96C-FF5ACE99E0B8Q26800135-23707F99-2FD4-4F9E-A1DC-6CCC0A7A74A8Q26801787-B7BCB689-EF9D-4B13-B24F-26C737C7FEC6Q26825467-51350E6B-96C5-4B8D-A7D0-AE430711E5B3Q26852545-3FD407D7-053C-4727-9BA3-6888AB9BD952Q27001566-12C4BC71-FDE0-49D5-A5F9-0993AF25E0D5Q27003124-D84B7EF2-C675-4B08-9239-5E6A4433DFBDQ27024341-EEA47D00-C615-4C47-B225-410B047A0B25Q27304365-2A5A6104-D8C8-449B-88C2-D38525409912Q27313900-BFFDA45E-ADCE-4074-ACED-69252BD06A94Q27332432-CD255764-0E25-4442-A63A-1687C9699DA9Q27333618-AF54DE4B-4274-4DAC-9803-2821B7694E0AQ28073947-4006DCB4-B7AF-4391-95C7-1E2A466D1E42Q28077024-97E174F8-9D9B-4128-9985-A52D95993997Q28080570-ED875E99-D083-4A62-A855-BE3B29B09823Q28083768-5C482C93-B1B3-4C4E-852E-82DE9E64CA25Q28115490-2B36F8AE-EB12-499B-9E67-FF2D1767A4DCQ28116119-BAC8444C-5E03-4974-944E-4EA131CDCFCFQ28192292-72EE830B-C43E-4F83-ABED-4D56CE7E74DAQ28212769-010AEB50-DA40-4907-BAC6-6C1721A449A6Q28268290-4265B6AB-AA26-4ADF-8080-33128EB1F93FQ28271189-42792EA0-9C6F-4460-9A39-9840B144FF55Q28275259-F0EDEA63-B9D6-49B6-993E-D40484E01BFCQ28345267-842610A3-2A98-47F2-9303-314EA2CE1193Q28346544-8A0E819A-C349-4D9D-A418-E059C8A6C7FFQ28347182-23454597-D39B-4EA0-B935-C65FD0100BCBQ28360727-1C083987-4835-4287-8581-DE1B96C35D43Q28363253-23900839-B804-4707-A9E5-EE9B4C642B83
P2860
Decreased lesion formation in CCR2-/- mice reveals a role for chemokines in the initiation of atherosclerosis.
description
1998 nî lūn-bûn
@nan
1998年の論文
@ja
1998年学术文章
@wuu
1998年学术文章
@zh
1998年学术文章
@zh-cn
1998年学术文章
@zh-hans
1998年学术文章
@zh-my
1998年学术文章
@zh-sg
1998年學術文章
@yue
1998年學術文章
@zh-hant
name
Decreased lesion formation in ...... initiation of atherosclerosis.
@en
Decreased lesion formation in ...... initiation of atherosclerosis.
@nl
type
label
Decreased lesion formation in ...... initiation of atherosclerosis.
@en
Decreased lesion formation in ...... initiation of atherosclerosis.
@nl
prefLabel
Decreased lesion formation in ...... initiation of atherosclerosis.
@en
Decreased lesion formation in ...... initiation of atherosclerosis.
@nl
P2093
P356
P1433
P1476
Decreased lesion formation in ...... initiation of atherosclerosis.
@en
P2093
P2888
P304
P356
10.1038/29788
P407
P577
1998-08-01T00:00:00Z
P6179
1037262209